253 results
Page 2 of 13
8-K
EX-10.1
4gxkeaj mivpx0
21 May 18
Entry into a Material Definitive Agreement
8:14am
8-K
EX-10.5
xk0rncyig70u
17 May 18
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
9:12am
8-K
EX-10.2
1i8aez
17 May 18
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
9:12am
8-K
EX-10.3
3q1q okgm
17 May 18
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
9:12am
8-K
EX-10.4
2ld8s8
17 May 18
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
9:12am
8-K
EX-10.1
g3oxb0su8h0w6235 i5
17 May 18
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
9:12am
8-K
EX-10.1
3c3qp8y0lsoap4emvma
8 May 18
BioDelivery Sciences Appoints Herm Cukier as Chief Executive Officer
4:41pm
8-K
EX-10.2
y3i 6pdo4j6uih
8 May 18
BioDelivery Sciences Appoints Herm Cukier as Chief Executive Officer
4:41pm
8-K
EX-10.3
vsm08vp7op40tt4 i9
8 May 18
BioDelivery Sciences Appoints Herm Cukier as Chief Executive Officer
4:41pm
8-K
EX-10.2
irzhjmb4ci
6 Feb 18
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva
12:00am
8-K
EX-10.1
7shl6cga
6 Feb 18
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva
12:00am
8-K
EX-10.1
jy8auh9fqw8a2
18 Jan 18
Entry into a Material Definitive Agreement
12:00am